Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma
نویسندگان
چکیده
AMA Grzegorczyk A, Marczyńska Z, Matkowski R, et al. Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma. Central European Journal Immunology. 2023. doi:10.5114/ceji.2023.130864. APA Grzegorczyk, A., Marczyńska, Z., Matkowski, R., Ziętek, M., Pietras, W., & Latos-Grażyńska, E. (2023). https://doi.org/10.5114/ceji.2023.130864 Chicago Aleksandra, Zuzanna Rafał Marcin Wojciech Elżbieta and Krzysztof Kałwak "Severe melanoma". Harvard E., Kałwak, K., Dachowska-Kałwak, I. MLA Aleksandra melanoma." Immunology, Vancouver Ziętek M, Pietras W, Latos-Grażyńska E
منابع مشابه
Nivolumab: Immunotherapy in Malignant Melanoma.
BACKGROUND Although patients diagnosed with melanoma that is confined to the skin have a five-year survival rate of 98%, this number drops to 16% with widely metastatic disease. Melanoma rates have been steadily increasing since the 1970s, but cytotoxic chemotherapy generally prolongs survival by about four months. Nivolumab is an effective immunotherapy agent. OBJECTIVES This article discuss...
متن کاملCombined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
BACKGROUND Nivolumab (a programmed death 1 [PD-1] checkpoint inhibitor) and ipilimumab (a cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] checkpoint inhibitor) have been shown to have complementary activity in metastatic melanoma. In this randomized, double-blind, phase 3 study, nivolumab alone or nivolumab plus ipilimumab was compared with ipilimumab alone in patients with metastatic mela...
متن کاملUkrain monotherapy in malignant melanoma (case report).
A patient with a metastasizing malignant melanoma (stage III) was treated with Ukrain monotherapy. Before and during the first Ukrain course of treatment the patient excreted melanin in the urine. After the third course melanin was no more detectable and the patient has been without any symptoms of disease for the last 12 years.
متن کاملHemophilic Pseudotumor of Humerus in an Adolescent with Severe Hemophilia A
This article has no abstract.
متن کاملIsolated Adrenocorticotropic Hormone Deficiency and Severe Hypercalcemia After Destructive Thyroiditis in a Patient on Nivolumab Therapy With a Malignant Melanoma
We describe a 58-year-old man with a malignant melanoma metastasis to the liver. After initiation of nivolumab therapy, he developed destructive thyroiditis and subsequently simultaneous isolated adrenocorticotropic hormone (ACTH) deficiency and severe hypercalcemia. Although isolated ACTH deficiency and hypercalcemia due to nivolumab therapy are both rare occurrences, these conditions can ofte...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Central European Journal of Immunology
سال: 2023
ISSN: ['1426-3912', '1644-4124']
DOI: https://doi.org/10.5114/ceji.2023.130864